MediciNova,Inc. 4875Short Interest
No institution currently reports a short position of 0.5% or more in MediciNova,Inc. (4875). The last disclosure was on 2019-09-18 (GOLDMAN SACHS INTERNATIONAL, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
2 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 1 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2019-07-22 |
|---|---|
| Latest disclosure | 2019-09-18 (GOLDMAN SACHS INTERNATIONAL, 0.49%) |
| Reporting institutions | 1 firms (2 reports) |
| Peak estimated short interest | 0.50% (2019-07-22, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2019-09-18 | GOLDMAN SACHS INTERNATIONAL | Position 216,549 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
Disclosure History 2 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2019-09-18 | GOLDMAN SACHS INTERNATIONAL | Position 216,549 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2019-07-22 | GOLDMAN SACHS INTERNATIONAL | Position 218,549 shares | Ratio 0.50% | ▲0.10% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| MIZUHO MEDY CO.,LTD.4595 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kubota Pharmaceutical Holdings Co.,Ltd.4596 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Solasia Pharma K.K.4597 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Delta-Fly Pharma,Inc.4598 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| StemRIM Inc.4599 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| CellSource Co.,Ltd.4880 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| FunPep Company Limited4881 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Perseus Proteomics Inc.4882 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Modalis Therapeutics Corporation4883 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kringle Pharma,Inc.4884 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |